Glycosylation in bladder cancer

International Journal of Clinical Oncology

Volumn 13, Issue 4, 2008, Pages 308-313

  Ohyama, Chikara ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Galectin; Glycoprotein; Glycosphingolipid; Proteoglycan

Indexed keywords

BLOOD GROUP ANTIGEN; GALECTIN; GLYCOPROTEIN; GLYCOSIDASE; GLYCOSPHINGOLIPID; HYALURONIC ACID; LECTIN; MONOCLONAL ANTIBODY; PROTEOGLYCAN;

APOPTOSIS; BLADDER CANCER; CANCER GROWTH; CARBOHYDRATE ANALYSIS; CARCINOGENESIS; GLYCOSYLATION; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVIEW;

BLOOD GROUP ANTIGENS; CARBOHYDRATE METABOLISM; GALECTINS; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; GLYCOSYLATION; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MEMBRANE GLYCOPROTEINS; PROTEOGLYCANS; URINARY BLADDER NEOPLASMS;

EID: 49749127215     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0809-8     Document Type: Review

References (42)

1. K. Furukawa K. Takamiya M. Okada 2001 Novel functions of complex carbohydrates elucidated by the mutant mice of glycosyltransferase genes Biochim Biophys Acta 1525 1 12
2. M. Fukuda 1996 Possible roles of tumor-associated carbohydrate antigens Cancer Res 56 2237 2244
3. S. Hakomori 2002 Glycosylation defining cancer malignancy: new wine in an old bottle Proc Natl Acad Sci U S A 99 10231 10233
4. R.D. Cummings I.S. Trowbridge S. Kornfeld 1982 A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc: α-D-mannoside β1,6 N-acetylglucosaminyltransferase J Biol Chem 257 13421 13427
5. K. Yamashita Y. Tachibana T. Ohkura 1985 Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced polyoma transformation J Biol Chem 260 3963 3969
6. J.W. Dennis S. Laferte C. Waghorne 1987 β1, 6 Branching of Asn-linked oligosaccharides is directly associated with metastasis Science 236 582 585
7. M. Fukuda S. Tsuboi 1999 Mucin-type O-glycans and leukosialin Biochim Biophys Acta 1455 205 217
8. M.F. Bierhuizen M. Fukuda 1992 Expression cloning of a cDNA encoding UDP-GlcNAc: Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen Proc Natl Acad Sci U S A 89 9326 9330
9. K. Shimodaira J. Nakayama N. Nakamura 1997 Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyl-transferase gene in human colorectal cancer: role of O-glycans in tumor progression Cancer Res 57 5201 5206
10. E. Machida J. Nakayama J. Amano 2001 Clinicopathological significance of core 2 beta 1, 6-N-acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization Cancer Res 61 2226 2231
11. R.V. Iozzo A.D. Murdoch 1996 Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function FASEB J 10 598 614
12. C. Ohyama S. Kanto K. Kato 2002 Natural killer cells attack tumor cells expressing high level of sialyl Lewis X oligosaccharides Proc Natl Acad Sci U S A 99 13789 13794
13. R.S. Bresalier P.S. Yan J.C. Byrd 1997 Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system Cancer 80 776 787
14. N. Oka Y. Takenaka A. Raz 2004 Galectins and urological cancer J Cell Biochem. 91 118 124
15. S. Kawamura C. Ohyama R. Watanabe 2001 Glycolipid composition in bladder tumor: a crucial role of GM3 ganglioside in tumor invasion Int J Cancer 94 343 347
16. C. Ohyama S. Kawamura K. Suzuki 1996 GM3 inhibits murine MBT-2 tumor invasion and growth Int J Oncol 8 809 813
17. R. Watanabe C. Ohyama H. Aoki 2002 Ganglioside GM3 over-expression induces apoptosis and reduces malignant potential in murine bladder cancer Cancer Res 62 3850 3854
18. A.R. Todeschini J.N. Dos Santos K. Handa 2008 Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway Proc Natl Acad Sci U S A 105 1925 1930
19. F. Yamamoto H. Clausen T. White 1990 Molecular genetic basis of the histo-blood group ABO system Nature 345 229 233
20. D.B. Haslam J.U. Baenziger 1996 Expression cloning of Forssman glycolipid synthetase: a novel member of the histo-blood group ABO gene family Proc Natl Acad Sci U S A 93 10697 10702
21. S. Kovarik I. Davidsohn R. Stejskal 1968 ABO antigens in cancer. Detection with the mixed cell agglutination reaction Arch Pathol 86 12 21
22. S. Bergman N. Javadpour 1978 The cell surface antigen A, B or O (H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report J Urol 119 49 51
23. T.J. Stephenson J.L. Williams K. Gelsthorpe 1985 Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences Br J Urol 57 148 153
24. E. Cuadrado A. Rodriguez-Trinidad E. Blasco 1986 Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study J Urol 135 409 415
25. C. Cordon-Cardo V.E. Reuter K.O. Lloyd 1988 Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma Cancer Res 48 4113 4120
26. D. Pode D. Golijanin Y. Sherman 1998 Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors J Urol 159 389 392
27. M.G. Friedrich A. Hellstern S.H. Hautmann 2002 Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests J Urol 168 470 474
28. K. Numahata M. Satoh K. Handa 2002 Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma Cancer 94 673 685
29. K. Murata E. Miyoshi M. Kameyama 2000 Expression of N- acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis Clin Cancer Res 6 1772 1777
30. Y. Ito E. Miyoshi M. Sakon 2001 Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1, 6 N-acetylglucosaminyl- transferase is an early event in hepatocarcinogenesis Int J Cancer 91 631 637
31. H. Dosaka-Akita E. Miyoshi O. Suzuki 2004 Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers Clin Cancer Res 10 1773 1779
32. T. Takahashi S. Hagisawa M. Kaku 2006 Predictive value of N-acetylglucosaminyltransferase-V (GnT-V) in superficial bladder cancer recurrence J Urol 175 90 93
33. H. Ishimura T. Takahashi H. Nakagawa 2006 N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer Clin Cancer Res 12 2506 2511
34. R.V. Iozzo A.D. Murdoch 1996 Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function FASEB J 10 598 614
35. B.P. Toole A. Zoltan-Jones S. Misra 2005 Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions Cells Tissues Organs 179 66 72
36. V.B. Lokeshwar G.L. Schroeder M.G. Selzer 2002 Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests Cancer 95 61 72
37. G.L. Schroeder M.F. Lorenzo-Gomez S.H. Hautmann 2004 A side by side comparison of cytology and biomarkers for bladder cancer detection J Urol 172 1123 1126
38. R. Golshani L. Lopez V. Estrella 2008 Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44 Cancer Res 68 483 491
39. L. Cindolo G. Benvenuto P. Salvatore 1999 Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas Int J Cancer 84 39 43
40. S. Akahani P. Nangia-Makker H. Inohara 1997 Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family Cancer Res 57 5272 5276
41. N. Oka S. Nakahara Y. Takenaka 2005 Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells Cancer Res 65 7546 7553
42. Y. Matsui S. Ueda J. Watanabe 2007 Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species Cancer Res 67 1212 1220